Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of pain and inflammation in the eye following cataract surgery. Nepafenac impurities refer to any unwanted or unintended substances that may be present in the Nepafenac drug substance or drug product, which could potentially affect its safety, efficacy, or quality. It is important to identify and control these impurities to ensure the safety and efficacy of the drug product. Various analytical techniques are used to detect and quantify Nepafenac impurities, which can include related compounds, degradation products, and residual solvents.
